Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mehmet Bilginsoy"'
Autor:
Todor Totev, Jasmina I. Ivanova, Mei Sheng Duh, Joseph H. Antin, Régis Peffault de Latour, Mehmet Bilginsoy, Lynn Huynh, Anuja Roy
Publikováno v:
Annals of Hematology. 99:743-752
This study assessed treatment patterns and healthcare resource utilization (HRU) of patients with severe aplastic anemia (SAA) with insufficient response to immunosuppressive therapy (IST). A retrospective chart review was conducted at Dana-Farber Ca
Publikováno v:
Journal of medical economics. 24(1)
To provide updated evidence in a series of analyses of U.S. trends over the past two decades in key financial metrics for branded drugs: market exclusivity periods (MEPs, the time between launch and first generic entry) for new molecular entities (NM
Autor:
R Peffault de Latour, Priyanka Bobbili, Lynn Huynh, Anuja Roy, Jasmina I. Ivanova, Duh, Joseph H. Antin, Todor Totev, Mehmet Bilginsoy
Publikováno v:
Value in Health. 21:S259-S260
Autor:
Joseph H. Antin, Todor Totev, Jasmina I. Ivanova, Mei Sheng Duh, Régis Peffault de Latour, Mehmet Bilginsoy, Lynn Huynh, Anuja Roy
Publikováno v:
Publons
Background: Aplastic anemia (AA) is a rare disease, with an incidence of 1-2 new cases per million per year in Europe and North America. Primary therapies for AA for patients who do not have a sibling or matched unrelated donor or are unfit for allog